Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-26 @ 12:32 AM
NCT ID:
NCT00047060
Group ID:
EG000
Title:
Stem Cell Transplant Therapy With Campath-1H
Description:
Subjects received a nonmyeloablative preparative regimen of alemtuzumab 30mg iv three times a week for two weeks followed by fludarabine 25mg/m2/day for five days followed by a PBPC graft targeted to deliver ≥ 5x106 CD34+ cells/kg. Cyclosporine A (CSA) for GVHD prophylaxis will be used initially with target CSA levels in the therapeutic range (200 -400 ng/ml).
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
5
Other Number Affected:
0
Other Number At Risk:
5
Study:
NCT00047060
Results Section:
NCT00047060
Adverse Events Module:
NCT00047060